3Prokofyeva E, Wegener A, Zrenner E. Cataract prevalence and prevention in Europe: a literature review. Acta Ophthalmologica, 2012, 91(5):395-405. 被引量：1
4Sternberg K, Terwee T, Stachs O, et al. Drug-induced secondary cataract prevention: experimental ex vivo and in vivo results with disulfiram, methotrexate and actinomycin D. Ophthalmic Res, 2010, 44(4):225-236. 被引量：1
3Black RL,Oglesby RB,Von Sallmann L,et a1.Posterior subcapsular cataracts induced by corticosteroids in patients with rheumatoid arthritis[J].JAMA,1960,174(9):166-171. 被引量：1
4Ernst P,Baltzan M,Deschenes J,et a1.Low-dose inhaled and nasal corticosteroid use and the risk of cataracts[J].Eur Respir J,2006,27(6):1168-1174. 被引量：1
6Black RL,Oglesby RB,von Sallmann L,et al.Posterior subcapsular cataracts induced by corticosteroids in patients with rheumatoid arthritis[J].JAMA,1960,1740):166-171. 被引量：1
7Valerio M.The hazards of prolonged local cortisone therapy[J].Bull Mem Soc Fr Ophtalmol,1963,76:572-580. 被引量：1
8Kewley GD.Possible association between beclomethasone diproprionate aerosol and cataracts[J].Aust Paediatr J,1980,16(2):117-118. 被引量：1
9Renfro L,Snow JS.Ocular effects of topical and systemic steroids[J].Dermatol Clin,1992,10(3):505-512. 被引量：1
10Ernst P,Baltzan M,Deschenes J,et al.Low-dose inhaled and nasal eorticosteroid use and the risk of cataracts[J].Eur Respir J,2006,27(6):1168-1174. 被引量：1
